Published in Blood on December 01, 1995
Global prevalence of putative haemochromatosis mutations. J Med Genet (1997) 4.03
Forging a field: the golden age of iron biology. Blood (2008) 3.83
Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta (2006) 2.23
Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta (2012) 1.74
Ferritin for the clinician. Blood Rev (2008) 1.46
Evolution of the iron-responsive element. RNA (2007) 1.27
Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder. Hum Genomics (2010) 1.25
Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem (2008) 1.22
A genome-wide detection of copy number variations using SNP genotyping arrays in swine. BMC Genomics (2012) 1.18
The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin. Br J Ophthalmol (2000) 1.10
Iron homeostasis and eye disease. Biochim Biophys Acta (2008) 1.08
Expression and function of iron-regulatory proteins in retina. IUBMB Life (2010) 1.03
Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy. RNA (2009) 0.97
A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload. Haematologica (2009) 0.96
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal (2013) 0.94
Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of chronically adapted Jurkat T cells to hydrogen peroxide. Free Radic Biol Med (2013) 0.91
Hereditary hemochromatosis and transferrin receptor 2. Biochim Biophys Acta (2011) 0.85
Transient overexpression of human H- and L-ferritin chains in COS cells. Biochem J (1998) 0.85
Activation of metallothioneins and alpha-crystallin/sHSPs in human lens epithelial cells by specific metals and the metal content of aging clear human lenses. Invest Ophthalmol Vis Sci (2003) 0.84
Hematologic biomarkers in childhood cataracts. Mol Vis (2011) 0.83
A novel mutation in the iron responsive element of ferritin L-subunit gene as a cause for hereditary hyperferritinemia-cataract syndrome. Blood (1996) 0.82
Mining Functional Elements in Messenger RNAs: Overview, Challenges, and Perspectives. Front Plant Sci (2011) 0.82
A child with hyperferritinemia: case report. Ital J Pediatr (2011) 0.81
Hyperferritinemia without iron overload in patients with bilateral cataracts: a case series. J Med Case Rep (2011) 0.81
Noncoding variation of the gene for ferritin light chain in hereditary and age-related cataract. Mol Vis (2013) 0.81
Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndrome. Orphanet J Rare Dis (2013) 0.80
Altered ferritin subunit composition: change in iron metabolism in lens epithelial cells and downstream effects on glutathione levels and VEGF secretion. Invest Ophthalmol Vis Sci (2010) 0.79
Changes in ferritin H- and L-chains in canine lenses with age-related nuclear cataract. Invest Ophthalmol Vis Sci (2008) 0.79
Mutation analysis of the ferritin L-chain gene in age-related cataract. Mol Vis (2010) 0.77
"Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch (2017) 0.75
Hepcidin levels in hereditary hyperferritinemia: Insights into the iron-sensing mechanism in hepatocytes. World J Gastroenterol (2010) 0.75
Homozygous mutation of the 5'UTR region of the L-Ferritin gene in the hereditary hyperferritinemia cataract syndrome and its impact on the phenotype. Haematologica (2013) 0.75
Anti-UVC irradiation and metal chelation properties of 6-benzoyl-5,7-dihydroxy-4-phenyl-chromen-2-one: an implications for anti-cataract agent. Int J Mol Sci (2011) 0.75
Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet (1998) 5.24
High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet (2000) 4.63
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet (2001) 4.15
Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet (1998) 3.93
Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet (1997) 3.39
Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet (1998) 3.08
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet (2000) 3.08
Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry (2001) 2.84
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet (1994) 2.55
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest (2001) 2.49
Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology (2000) 2.44
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet (1999) 2.05
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med (2000) 1.94
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med (1999) 1.92
Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet (1997) 1.85
Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet (1999) 1.83
MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet (2001) 1.78
Mutations in a novel gene with transmembrane domains underlie Usher syndrome type 3. Am J Hum Genet (2001) 1.76
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol (1998) 1.74
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet (1999) 1.65
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol (1993) 1.58
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene (2011) 1.58
Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med (2000) 1.53
(TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome. Haematologica (1999) 1.53
Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy (2002) 1.51
Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens (1998) 1.51
Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins. Hum Mutat (2000) 1.49
Molecular basis of childhood deafness resulting from mutations in the GJB2 (connexin 26) gene. Hum Genet (2000) 1.48
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis (2001) 1.44
Analysis of 14 cystic fibrosis mutations in five south European populations. Hum Genet (1991) 1.40
Seismic evidence of an extended magmatic sill under Mt. Vesuvius. Science (2001) 1.39
Thrombotic thrombocytopenic purpura developed during ticlopidine therapy. Haematologica (1993) 1.39
Heterogeneity of hemochromatosis in Italy. Gastroenterology (1998) 1.38
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood (2001) 1.33
Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet (1998) 1.33
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness. Proc Natl Acad Sci U S A (2007) 1.22
Espin gene (ESPN) mutations associated with autosomal dominant hearing loss cause defects in microvillar elongation or organisation. J Med Genet (2005) 1.21
New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet (2005) 1.20
High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome. Clin Endocrinol (Oxf) (2013) 1.16
A novel mutation in SACS gene in a family from southern Italy. Neurology (2004) 1.15
A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol (1995) 1.15
Functional analysis of mutations in SLC7A9, and genotype-phenotype correlation in non-Type I cystinuria. Hum Mol Genet (2001) 1.13
Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol (2001) 1.12
Screening of 62 mutations in a cohort of cystic fibrosis patients from north eastern Italy: their incidence and clinical features of defined genotypes. Hum Mutat (1993) 1.12
Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. Am J Hum Genet (1997) 1.11
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1997) 1.09
Severe impairment of antioxidant system in human hepatoma. Cancer (1986) 1.07
Delta F508 gene deletion in cystic fibrosis in southern Europe. Lancet (1989) 1.06
The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients. Hepatology (1996) 1.06
The genomic organization of the Fanconi anemia group A (FAA) gene. Genomics (1997) 1.05
Ca(2+)-activated K+ transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins. J Biol Chem (1993) 1.05
Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism (1999) 1.04
Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. Br J Haematol (2000) 1.04
Analysis of ferritins in lymphoblastoid cell lines and in the lens of subjects with hereditary hyperferritinemia-cataract syndrome. Blood (1998) 1.04
Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology (1997) 1.04
The detached osteochondral fragment as a source of cells for autologous chondrocyte implantation (ACI) in the ankle joint. Osteoarthritis Cartilage (2005) 1.03
A novel GJA1 mutation causes oculodentodigital dysplasia without syndactyly. Am J Med Genet A (2005) 1.03
Prenatal diagnosis of recurrence of cystic hygroma with normal chromosomes. Prenat Diagn (1985) 1.03
Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood (1994) 1.03
Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families. Eur J Hum Genet (1997) 1.02
Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II). Blood (1997) 1.02
Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR). Br J Haematol (1998) 1.02
Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport. J Clin Invest (1997) 1.02
Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations. Hum Genet (1995) 1.00
A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features. J Med Genet (2011) 1.00
Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions. Genomics (1998) 1.00
Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy (2001) 1.00